Photys Therapeutics’ $186 Million Research Collaboration with Novo Nordisk

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Photys Therapeutics in the transaction. Photys Therapeutics (Photys), a proximity-based therapeutics company, announced its multi-year collaboration and license...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here